INTRODUCTION TO THE ADVISORY BOARD:
The mission of the Advisory Board is to carry out the analysis and discussion to provide the strategic guidance on the global health challenges in the context of Health 4.0 ecosystem. The advisory board is also responsible to publish the main guiding principles and recommendations that impact in the Transformation of Medicine & Care, Health Sciences and Heath Industry, in alignment with the following key drivers:
- Policymaking leadership
- Regulatory and legal development
- Science, technology and industry lifecycles monitoring and forecasting
- Innovation and social behavioural modelling
- Integration and Investment decision-making
The Advisory Board advises and orientates on the best practices with regards to the creation, the implementation and the management of „value-based Healthcare“ systems in Europe and beyond, while supporting the mission and vision of the MEDICINALE. Club.
The Advisory Board is transdisciplinary and international. Based on knowledge about Neuroleadership and Dunbar-Numbers in context with the Social Brain Hypothesis the Advisory Board is composed of 15 Members.
Chairman of the Advisory Board – Alois Steidel
Alois G. Steidel is the Founder, Owner, and CEO of K|M|S Sales and Services AG, Unterhaching (Munich).Since 1996, Alois G. Steidel has been managing partner, and, with the transformation of the company into a public company in 2010, he became CEO of K|M|S Sales and Services. Before founding K|M|S, Mr Steidel has been involved in several companies working on innovative IT products and solutions including software for airlines, as well as clinical pathways for patient care. Today, Alois G. Steidel and his team became one of the leading providers of knowledge management systems in the healthcare industry. With the innovative software solutions eisTIK.NET® and EYE ON HEALTH® K|M|S positioned itself as market leader for management information systems in the German health care / hospital market. In the 1990s, Alois G. Steidel helped developing a case-based lump-sum fee system (precursor of the DRG System) for inpatient care of complex diseases in German hospitals and then became a co-developer for the German DRG System. Investments in various organizations and his membership in several supervisory boards help strengthening his network and relevant partnerships. As a leading knowledge manager in the German health care market, K|M|S always wants to be “one step ahead” to offer to its customers and partners solutions that will help to better manage emerging problems and necessary changes in the market. Alois is the Chairman of the Advisory Board of XPOMET Medicinale and holds numerous leading positions in the healthcare landscape: www.kms.ag www.cdgw.de www.clubcorbeau-bruessel.com www.ayinger-gespraeche.de